Bosh sahifa688235 • SHA
add
BeOne Medicines AG
Yopilish kursi
237,12 ¥
Kunlik diapazon
235,34 ¥ - 242,10 ¥
Yillik diapazon
194,44 ¥ - 346,00 ¥
Bozor kapitalizatsiyasi
247,17 mlrd CNY
Oʻrtacha hajm
2,05 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
SHA
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,50 mlrd | 32,84% |
Joriy xarajat | 1,17 mlrd | 11,85% |
Sof foyda | 66,50 mln | 143,79% |
Sof foyda marjasi | 4,44 | 132,96% |
Har bir ulushga tushum | 0,58 | — |
EBITDA | 219,47 mln | 822,86% |
Amaldagi soliq stavkasi | 55,44% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 4,55 mlrd | 73,08% |
Jami aktivlari | 8,19 mlrd | 38,30% |
Jami passivlari | 3,83 mlrd | 47,85% |
Umumiy kapital | 4,36 mlrd | — |
Tarqatilgan aksiyalar | 110,94 mln | — |
Narxi/balansdagi bahosi | 6,03 | — |
Aktivlardan daromad | 5,85% | — |
Kapitaldan daromad | 8,73% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 66,50 mln | 143,79% |
Operatsiyalardan naqd pul | 417,35 mln | 455,28% |
Sarmoyadan naqd pul | -38,34 mln | 59,05% |
Moliyadan naqd pul | 96,93 mln | 2 243,07% |
Naqd pulning sof oʻzgarishi | 499,10 mln | 768,32% |
Boʻsh pul | 385,44 mln | 9 151,22% |
Haqida
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has locations on six continents, in over 45 countries. BeOne has a large presence in the Chinese market.
BeOne Medicines has developed several medicines, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November 2024 the company announced its intention to rebrand as BeOne Medicines. BeOne changed its stock ticker to ONC in January 2025 and redomiciled to Basel, Switzerland in May 2025. Wikipedia
Tashkil etilgan
28-okt, 2010
Xodimlar soni
12 000
